ImmunologyImmunoTargets and TherapyPeer-reviewed
Targeting B and T lymphocyte attenuator regulates lupus disease development in NZB/W mice
Léa Gherardi, Lucie Aubergeon, Mélanie Sayah…·Fanny Monneaux
This study shows that targeting BTLA with a monoclonal antibody delays lupus onset and improves survival in NZB/W mice by reducing follicular B cells and exhibiting agonist activity.
1 citation